Amster Labs Limited IPO Details
SME
Amster Labs IPO DRHP (Draft Red Herring Prospectus) has been Filed with Exchange.
Pre-issue shareholding stands at 1,48,37,603, which will increase to 2,01,46,403 post-issue.
The Lead Managers for Amster Labs IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Fast Track Finsec Pvt Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.
For detailed information, Refer to the Amster Labs Limited DRHP.
Amster Labs IPO Details
Amster Labs IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
To be announced | |||
Amster Labs IPO Reservation
Promoter Holding
Documents
Amster Labs IPO Valuations
Amster Labs Financial Information
| Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 110.63 | 75.38 | 69.05 |
| Total Income | 35.5 | 105.29 | 96.97 |
| Profit After Tax | 5.8 | 2.43 | 1.23 |
| Net Worth | 16.55 | 11.78 | 9.44 |
| Reserves and Surplus | 9.12 | 8.36 | 6.03 |
| Total Borrowing | 39.99 | 28.88 | 24.89 |
| Amount in ₹ Crore | |||
About Amster Labs IPO
Incorporated in September 2014, Amster Labs Limited manufactures and distributes pharmaceutical products.
The company offers a diverse range of pharmaceutical products, including ethical drugs, generic medications, and OTC solutions.
The company's portfolio includes Softgel Capsules, Herbal Soft Gelatin Capsules, Carotenoids, and Calcitriol Soft Gelatin Capsules.
They specialize in General & Beta Lactam Tablets, syrups, ointments, and powder injections for treatments such as anti-diabetic therapies, analgesics, antibiotics, and supplements.
The company's manufacturing unit is situated in Baddi, Himachal Pradesh, covering an area of 75000 square feet.
The company has ISO 9001:2015 and ISO 10002:2018 certifications to ensure product quality.
As of March 31, 2024, there are 64 employees, all on payroll and none on contract.
Competitive Strength:
- Experienced Promoters and Senior Management with extensive domain knowledge.
- Quality assurance and control.
- Investment in latest technology and maintain our edge in the market.
- Strong sales, marketing, and distribution capabilities.
- Large and rapidly growing R&D capabilities across our product portfolio.
- Strategic presence across the pharmaceutical value chain.
Strength Of Amster Labs IPO
Risk Of Amster Labs IPO
Objectives Amster Labs IPO
1. Setting up of new manufacturing unit and unification of existing divisions
2. Working Capital Requirement
3. General Corporate Purposes
Company Contact Details
Amster Labs Ltd.
SCO 166-167, Level 1,
Sector 9C, Madhya Marg,
Sector 9
Chandigarh, Chandigarh, 160009
Phone: 0172-4183370
Email: cs@amsterlabs.in
Website: http://www.amster.in/
Registrar Contact Details
Lead Mangers
Lead Manager Reports
Market Maker
To be announced